이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Beijing Tong Ren Tang Chinese Medicine 관리
관리 기준 확인 0/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Wang Chi
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | less than a year |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | less than a year |
| 이사회 평균 재임 기간 | 2.2yrs |
최근 관리 업데이트
Recent updates
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders
Sep 06
Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?
Sep 02Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk
Feb 05Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Jan 03A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Sep 28Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today
Jul 12Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?
Mar 29Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28
Apr 28Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28
Mar 25Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?
Oct 27Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 28Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Mar 11What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Feb 04Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?
Jan 18
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?
Dec 29Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Dec 11Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 23CEO
Wang Chi (49 yo)
less than a year
테뉴어
Mr. Wang Chi is Executive Director and Chief Executive Officer of Beijing Tong Ren Tang Chinese Medicine Company Limited from May 10, 2024. Mr. Chi has experience in Medical and Pharmaceutical industry. Mr...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | 데이터 없음 | 데이터 없음 | |
| Executive Director & Executive Deputy GM | less than a year | HK$975.00k | 0.0073% HK$ 563.9k | |
| CEO & Executive Director | less than a year | 데이터 없음 | 데이터 없음 | |
| CFO & Company Secretary | 4.4yrs | 데이터 없음 | 데이터 없음 | |
| Deputy GM & General Counsel | no data | 데이터 없음 | 데이터 없음 |
0.6yrs
평균 재임 기간
50yo
평균 연령
경험이 풍부한 관리: 3613 의 관리팀은 경험 (평균 재직 기간 0.5 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | 데이터 없음 | 데이터 없음 | |
| Executive Director & Executive Deputy GM | 4.6yrs | HK$975.00k | 0.0073% HK$ 563.9k | |
| CEO & Executive Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | 7.1yrs | HK$288.00k | 데이터 없음 | |
| Independent Non-Executive Director | 11.5yrs | HK$288.00k | 데이터 없음 | |
| Non-Executive Director | 2.2yrs | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | 1.6yrs | HK$240.00k | 데이터 없음 |
2.2yrs
평균 재임 기간
53yo
평균 연령
경험이 풍부한 이사회: 3613 의 이사회는 경험(평균 재직 기간 2 년)으로 간주되지 않으므로 새 이사회가 필요합니다.